aMusculoskeletal Research, Department of Medical Chemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
bStayble Therapeutics AB, Gothenburg, Sweden
cDepartment of Radiology, Läkarhuset Odenplan, Stockholm, Sweden
dDepartment of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
eStockholm Spine Center, Löwenströmska Hospital, Upplands Väsby, Sweden
fKarolinska Institutet, Stockholm, Sweden.
Address correspondence and reprint requests to Kjell Olmarker, MD, PhD, Musculoskeletal Research, Department of Medical Chemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, SE–405 30 Gothenburg, Sweden; E-mail: [email protected]
Received 21 April, 2020
Revised 17 June, 2020
Accepted 20 July, 2020
The device(s)/drug(s) that is/are the subject of this manuscript is/are not FDA-approved for this indication and is/are not commercially available in the United States.
Stayble Therapeutics AB, Gothenburg, Sweden funds were received in support of this work.
Relevant financial activities outside the submitted work: stocks, employment.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.spinejournal.com).
